Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07684664Not ApplicableNot Yet Recruiting

Allurion Gastric Balloon PAS

Role: lead

NCT05368259Not ApplicableActive Not Recruiting

The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)

Role: lead

NCT03261453Not ApplicableCompleted

THE ENLIGHTEN STUDY

Role: lead

NCT05884606Not ApplicableCompleted

The Allurion Digital Behaviour Change Intervention

Role: lead

NCT02802007Not ApplicableUnknown

Pilot Trial of the Elipse™ Intragastric Balloon System for the Treatment of Overweight and Obese Individuals

Role: lead

All 5 trials loaded